Direct reprogramming of stem cell properties in colon cancer cells by CD44

Cancer progression is commonly segregated into processes of primary tumour growth and secondary metastasis. Recent evidence suggests that a subpopulation of cancer cells, cancer stem cells (CSCs), is responsible for tumour growth in cancer. However, the role of CSCs in cancer metastasis is unclear. In this study, we found that the C terminus of CD44 contributes to sphere formation and survival in vitro via the CD44–SRC–integrin axis. In addition, nuclear CD44/acetylated‐STAT3 is required for clonal formation in vitro and tumourigenicity in vivo . Nuclear CD44 binds to various promoters identified by chromatin immunoprecipitation‐seq, including that of c‐myc and Twist1 , leading to cell fate change through transcriptional reprogramming. We propose that nuclear CD44/acetylated‐STAT3 performs an unexpected tumour‐progressing function by enhancing cell outgrowth into structures where cells with properties of CSCs can be generated from differentiated somatic cells in suspension culture, and then exhibit attributes of cells that have undergone an epithelial–mesenchymal transition, leading to tumour metastasis, and a resulting worse prognosis. CD44 is a known marker for cancer stem cells (CSCs) and had functionally been associated with cancer metastasis. This paper highlights the functional contribution of CD44 in determining cellular features of CSCs that include the definition of underlying molecular mechanisms.